Skip to main content
. 2014 Jan 2;8(1):e2536. doi: 10.1371/journal.pntd.0002536

Table 1. Association between demographic factors and VL relapse.

Risk factor Cured cohort Relapse cohort Unadjusted odds ratio (95% CI) p
Sex (n = 8537) 8418 119
Male 4745 (56.4) 83 (69.7) 1.8 (1.2–2.6) 0.003
Female 3673 (43.6) 36 (30.3) - -
Castea (n = 8486) 8368 118
Scheduled caste 2453 (29.3) 32 (27.1) 1.4 (0.7–2.7) 0.32
Other backward class 4624 (55.3) 74 (62.7) 1.7 (0.9–3.2) 0.08
General Category 1291 (15.4) 12 (10.2) - -
Living in MSF-supported blocks (n = 8537) 8418 119
No 4297 (51.0) 56 (47.1) 0.9 (0.6–1.2) 0.39
Yes 4121 (49.0) 63 (52.9) - -
Previous relapse (n = 8537) 8418 119
Multiple 18 (0.2) 1 (0.8) 3.9 (0.1–25.4) 0.23c
Single 299 (3.6) 4 (3.4) 0.95 (0.3–2.5) 1.00c
No 8101 (96.2) 114 (95.8) - -
Age, years (n = 8537) 8418 119
<5 574 (6.8) 17 (14.3) 3.6 (1.8–7.1) <0.001
5 to <15 3229 (38.4) 43 (36.1) 1.6 (0.9–2.9) 0.10
15 to <30 1935 (23.0) 16 (13.4) - -
30 to <45 1490 (17.7) 21 (17.6) 1.7 (0.9–3.3) 0.11
≥45 1190 (14.1) 22 (18.5) 2.2 (1.2–4.3) 0.013
Treatment location (n = 8537) 8418 119
Treatment camps (ambulatory) 162 (1.9) 0 NA -
Primary health center (ambulatory) 1372 (16.3) 13 (10.9) 0.6 (0.3–1.1) 0.10
Hospital (inpatient) 6884 (81.8) 106 (89.1) - -
Season of treatment (n = 8537) 8418 119
March–June 3566 (42.4) 53 (44.5) 1.0 (0.7–1.6) 0.84
July–October 2527 (30.0) 33 (27.7) 0.9 (0.6–1.5) 0.74
November–February 2325 (27.6) 33 (27.7) - -
Year of treatmenta , b (n = 7471) 7359 112
2011 1692 (23.0) 31 (27.7) 1.4 (0.8–2.2) 0.22
2010 1614 (21.9) 25 (22.3) 1.1 (0.7–1.9) 0.61
2009 1468 (19.9) 21 (18.8) 1.1 (0.6–1.8) 0.84
2007–2008 2585 (35.1) 35 (31.3) - -

a The remaining data were missing or incorrectly coded in the database.

b The data from years 2007 and 2008 were combined, as operations began mid-2007. Patients treated in 2012 were excluded, as there would be limited time for relapse to present.

c Fisher's Exact test.